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Abstract. We have generated mice transgenic for a hu- 
man multidrug resistance (MDR)3 mini-gene driven by 
a hamster vimentin promoter. The MDR3 gene en- 
codes a P-Glycoprotein that resembles the mouse mul- 
tidrug resistance 2 P-Glycoprotein shown to be in- 
volved in the translocation of the phospholipid 
phosphatidylcholine through the hepatocyte canalicu- 
lar membrane (Smit et al., 1993. Cell. 75:451-462).  The 
vimentin promoter drives expression of the MDR3 
transgene in mesenchymal tissues and in the eye lens. 
We show here that the presence of human multidrug 
resistance 3 P-Glycoprotein in the lens results in a se- 
vere lenticular pathology. Lens structural abnormalities 
initiate at a late embryonic stage and increase during 
postnatal lens development. Differentiation of the pri- 
mary fibers is affected, and the terminal differentiation 
of the lens epithelium into secondary fibers is also per- 
turbed. The ultrastructural alterations, particularly of 
the lens plasma membranes, resemble those identified 
in congenital mouse osmotic cataract. 
p 
-GLYCOPROTEINS (pgp)l are highly conserved mem- 
brane proteins that can function as ATP-dependent 
efflux pumps (23, 31, 57). They belong to the family 
of ATP-binding cassette  transporter proteins  (37). Two 
genes for Pgps  have been identified in humans: human 
multidrug resistance gene (MDR)I and MDR3 (also called 
MDR2 [10, 72, 73], and three in mice: mouse multidrug re- 
sistance  gene (mdr)l  (or mdrlb), mdr3 (or mdrla),  and 
mdr2 (16, 33, 35). 
The human multidrug resistance  (MDR)I Pgp (and the 
related murine mdrl  and mdr3,  and hamster pgpl  and 
pgp2  Pgps),  can  extrude  a  wide  range  of hydrophobic 
drugs from mammalian cells (18, 34, 42, 70). Increased lev- 
els of these proteins in cancer cells result in MDR. De- 
fense against  naturally occurring  xenobiotic (toxic)  com- 
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pounds may represent the main physiological function of 
these Pgps (60). Attempts to show that the human MDR3 
or the closely related mouse mdr2 Pgp  (91%  identity at 
the amino acid level) can confer MDR have been negative 
thus far (5, 35, 58, 73). 
To find a physiological function for this class of Pgps, we 
have generated mice that are either unable to make the 
mdr2 Pgp or overproduce the MDR3 Pgp in many tissues 
(64; Smit, J.J.M., F. Baas, J.E. Hoogendijk, G. Jansen, F. 
Jennekens, M.A.  van  der  Valk,  A.H.  Schinkel,  A.J.M. 
Berns, K. Nooter, and P.  Borst, manuscript in prepara- 
tion). Mice  homozygous for a  disrupted mdr2 gene de- 
velop liver disease. A detailed analysis of these mice has 
shown that the mouse mdr2 Pgp (and presumably there- 
fore also  its  human MDR3 counterpart) is essential  for 
translocating phosphatidylcholine through the hepatocyte 
canalicular membrane into the bile (64, 65). This indicates 
that this Pgp is a specific phospholipid translocator, as has 
recently been supported by in vitro experiments (54, 66). 
We  have  generated mice  containing an MDR3  mini- 
gene  under  the  control  of a  vimentin promoter  which 
drives the expression of the transgene in mesenchymal tis- 
sues and in the eye lens. These mice develop a peripheral 
neuropathy and microphthalmia. Here we present an anal- 
ysis of the abnormalities in the lenticular cells  of these 
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cytochemical  and  ultrastructural  observations  show that 
the expression  of the transgene product progressively in- 
duces  cell  membrane  alterations  that  resemble  those 
known to perturb the control of the vectorial electrochem- 
ical gradient across the lens. As a consequence, a postnatal 
cataract develops that may be osmotic in nature. 
Materials and Methods 
Transgenic Mice 
We have generated mice containing an MDR3 mini-gene under the con- 
trol of a vimentin promoter which drives the expression of the transgene 
in mesenchymal tissues and in the eye lens. In this study, we have exam- 
ined lenses from mice of the transgenic Friend Virus B (FVB) strains VO1 
and VO4. Control lenses were either selected from wild-type offspring ob- 
tained from the same litter as the transgenic offspring or from mating of 
the wild-type FVB mouse strain. 
Lens Samples 
Embryos were obtained from crosses of VO1  and VO4 transgenic mice 
with wild-type FVB mice. Animals were mated overnight, and those with 
vaginal plugs were separated the following morning, which was considered 
to be gestational day 1 (El). Pregnant mice were killed on E12 and El4, 
and the complete eyes were dissected from the embryos. Lenses or intact 
eye  s from newborn (1-8 d after birth) and adult mice (between 2 wk and 4 
mo old) were also examined. The material was rapidly fixed by immersion 
in cold (-20°C) 100% acetone or methanol, or in 3% paraformaldehyde 
in PBS, pH 7.4, at 4°C for 1 h. 
For cryosectioning, the dissected lenses or the whole eyes were washed 
in PBS and impregnated in 2.3 M sucrose-PBS overnight at 4°C. Samples 
were frozen and subsequently stored in liquid nitrogen. Cryosections of 
1 I~m were made at -85°C with the Ultracut E (Reichert Jung S.A., Rueil, 
France) equipped with an FC4D cryoattachment as described by Toko- 
yasu (68). 
Antibodies 
We used affinity-purified rabbit polyclonal antibodies (polyvim K34) di- 
rected against vimentin (53)  at 1:200  dilution (Organon Teknica, Turn- 
hout, Belgium); rabbit polyclonal antibodies directed against the major in- 
trinsic membrane protein of the lens fibers (MP26) at 1:500 dilution (19); 
mouse mAb C219, recognizing an epitope present in all human and mouse 
Pgps, at 1:100  dilution (28, 65); and affinity-purified rhodamine-labeled 
donkey  secondary  antibodies  directed  against  rabbit  and  mouse  IgG 
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). For im- 
munogold labeling, we used as secondary antibodies goat anti-mouse IgG 
conjugated to 5- or 10-nm gold particles (Amersham International, Little 
Chalfont, UK), or protein A conjugated to 10-rim gold particles (Depart- 
ment of Cell Biology, University of Utrecht, The Netherlands). 
RNA Analyses 
Total RNA from tissues was isolated by acidic guanidinium isothiocya- 
nate-phenol-chloroform and was analyzed by RNase protection as described 
(64). The plasmid construct for detection of MDR3 contains a 310-nucleotide 
HindII-TaqI fragment (64). For detection of glyceraldehyde-3-phosphate 
dehydrogenase (gapdh) mRNA, a  146-bp BsteII-HindIII fragment from 
pmGAP was blunted and cloned in a SmaI site of pGEM3-Zf(-). To syn- 
thesize antisense RNA probes, we linearized the plasmid templates with 
BamHI  (gapdh) and  HindlII  (MDR3), and transcribed  them with 3-7 
RNA polymerase. 32p-labeled RNA transcripts were hybridized with 10 
p~g of total RNA from the tissue of interest. The protected probe was visu- 
alized by electrophoresis through a denaturing 6% gel, followed by auto- 
radiography. 
SDS-PAGE and Immunoblotting 
Decapsulated lenses of control and transgenic mice were homogenized in 
40 mM KC1, 2 rhM MgCI2, and 50 mM Tris-HC1, pH 7.5 (TKM buffer), 
containing 2  mM PMSF. After two washes in TKM buffer, the plasma 
membrane--cytoskeleton  complex obtained by centrifugation at 3,000 g for 
10 rain was subsequently treated with 4 M urea for 15 min. The urea-insol- 
uble material was collected by centrifugation at 100,000 g for 45 min. SDS- 
PAGE was carried out in 12 and 10% polyacrylamide slab gels according 
to Laemmli (see also 20) using a miniprotean If slab cell (Bio-Rad Labo- 
ratories, Richmond, CA) operating at 180 V for 1 h. Aliquots of the differ- 
ent samples were solubilized in sample buffer (2% SDS, 5% 2-13-mercap- 
toethanol) without heating. After electrophoresis, the gels were stained 
with Coomassie blue. 
Proteins separated by SDS-PAGE were electrophoretically transferred 
onto nitrocellulose paper and incubated with the primary antibodies as 
described  (20).  Alkaline phosphatase--conjugated or  HRP-labeled  goat 
anti-mouse or anti-rabbit IgG were used as secondary antibodies (Pro- 
mega Biotec, Madison, WI). For alkaline phosphatase-coujugated anti- 
bodies, the color reaction was developed with 5-bromo-4-chloro-3-indolyl 
phosphate/nitroblue  tetrazolium  (BCIP/NBT  kit;  Kirkegaard  &  Perry 
Laboratories, Inc., Gaithersburg, MD). For HRP-labeled antibodies, en- 
hanced chemiluminescence detection  was  performed  (ECL  kit;  Amer- 
sham International). 
Immunofluorescence 
Immunofluorescence experiments were performed on 1-1xm cryosections, 
placed onto poly-L-lysine-coated coverslips. Sections were fixed with 3% 
paraformaldehyde-PBS for 10 min, thoroughly washed in PBS, and incu- 
bated in a quenching solution of 50 mM NH4CI-PBS for 20 min and in a 
blocking solution (PBS-0.2%  gelatin) for 30 min. Immunolabeling was 
performed by incubating the sections consecutively in the primary and in 
the rhodamine-labeled secondary antibodies for 45 min. 0.2% gelatin-PBS 
solution was used for antibody dilutions and washes. Nuclei of cells were 
stained with 4,6-diamidino-2-phenylindole, 0.1  mg/ml in PBS, for 5 min. 
Sections were mounted using Mowiol (Hoechst, Frankfurt, Germany) and 
examined with a  microscope (Aristoplan; E.  Leitz,  Inc., Wetzlar, Ger- 
many) equipped with epifluorescence illumination and with x63 NA 1.4 
and x 100 NA 1.32 immersion optics. 
Con  focal Laser Scanning Microscopy 
Confocal laser scanning microscopy was performed using an MRC-600 
(Bio-Rad Laboratories) mounted on a  microscope (Optiphot  II; Nikon 
Inc., Garden City, NY) equipped with a x60 objective (plan apochromatic 
NA 1.4), on 2.5-~m cryosections processed for immunofluorescence  as de- 
scribed before. For rhodamine, a  helium-neon ion laser adjusted at 543 
nm was used, close to the maximum of absorption. The signal was treated 
by Kalman filter (average eight images), and the pinhole of the confocal 
system was adjusted to allow a field depth of ~0.6 p.m. A focal series of up 
to 10 sections apart was collected for each specimen and then processed to 
produce single composite images (extended focus) with high spatial reso- 
lution. 
Photographs were taken on film (Kodak T-Max; Eastman Kodak Co., 
Rochester, NY) using a  camera mounted on a  film recorder (VM-1710; 
Lucius & Baer, Geretsried, Germany). 
Histological Sections 
Lenses or intact eyes were fixed overnight in a mixture of 0.25% glutaral- 
dehyde and 3% paraformaldehyde-PBS at 4°C. After washing in PBS, the 
samples were dehydrated in a series of graded ethanol solutions and em- 
bedded in LR white. 1.5-mm semithin sections were placed onto poly-L- 
lysine-coated slides, dried, stained with 1% toluidine blue, and examined 
with a Leitz Aristoplan microscope. 
Electron Microscopy 
Four thin-section EM lenses were fixed in 2% glutaraldehyde in 0.2 M ca- 
codylate buffer, pH 7.4,  for 1 h, washed in the same buffer, and subse- 
quently fixed in a mixture of 1% osmium tetroxide/0.8% potassium ferro- 
cyanate in the same buffer for 40 min. After washing, the samples were 
dehydrated in a series of graded ethanol solutions and embedded in Epon 
Araldite. Thin sections were stained with uranyl acetate and lead citrate. 
Immunogold labeling  was  performed  on  1-~m cryosections  of  3% 
paraformaldehyde- or methanol-fixed intact tissue with the same protocol 
described for immunofluorescence, using as secondary antibodies the cor- 
The Journal of Cell Biology, Volume 132, 1996  702 Figure 1.  The level of MDR3 mRNA in the transgenic lens. Total 
RNA was isolated from the lenses of transgenic (7) V01 animals 
or wild-type (IV) animals and analyzed by RNase protection. The 
protected  fragments  representing  MDR3,  mdr2,  and  gadph 
mRNA are indicated on the right side. For comparison, an analy- 
sis of MDR3 expression levels in RNA isolated from a  human 
liver and a  V01  transgenic mouse liver. Due  to the partial se- 
quence homology of the MDR3-specific RNA probe with mouse 
mdr2 sequences, a smaller fragment was detected that represents 
mdr2 mRNA in RNA from liver. As size marker (M), an end- 
labeled DdeI digest of M13mpl9 DNA was used; relevant sizes 
are indicated at the left. 
responding gold conjugates. The immunogold-labeled  cryosections were 
postfixed in 2% glutaraldehyde  in 0.2 M cacodylate buffer for 30 min and 
in 1% osmium tetroxide in the same buffer for 45 min, and then processed 
for thin sections as described before. To favor the immunogold labeling, 
some cryosections were fixed with 1.5% paraformaldehyde  for 20 min, ex- 
tracted for 5 min with 1% Triton X-100 in PBS, postfixed with 100% cold 
methanol (-20°C), and then processed for immunogold  labeling. Other 
lens samples were extracted with 1% Triton X-100 in TKM, after repeated 
washing in the same buffer, fixed in 1.5% paraformaldehyde  for 20 min, 
and processed  for cryosectioning and immunogold labeling using the C219 
antibody. After the latter step, the cryosections were embedded either in 
Epon or in LR white. Thin sections of this material were stained with ura- 
nyl acetate. 
For freeze fracturing,  small  pieces  of the 2%  glutaraldehyde-fixed 
lenses were washed in PBS and gradually impregnated with 30% glycerol/ 
PBS overnight at 4°C. Each piece was mounted in a specimen holder, rap- 
idly frozen in Freon 22, (Dehon, Paris, France) and stored in liquid nitro- 
gen. Freeze fracturing was performed at -120°C or at -150°C in a freeze- 
fracture apparatus (model 301; Balzers, Liechtenstein).  After fracture, the 
specimens  were immediately  shadowed  by platinum/carbon  evaporation 
from an electron gun. 
Figure 2.  (A) Immunoblot anal- 
ysis  of  urea-insoluble  lens 
plasma  membrane  fractions 
from newborn transgenic mouse 
lenses (lane a) and of cataractous 
adult  transgenic  mouse  lenses 
(lane  b).  For  comparison,  an 
urea-insoluble  fraction  of  eye 
tissue of a  control mouse after 
removal of the lens (lane c). Pro- 
tein  blots  were  incubated  with 
the Pgp-reactive mAb C219. De- 
tection was done by chemilumi- 
nescence. (B) Immunoblot anal- 
ysis  of  urea-insoluble  lens 
plasma  membrane  fractions 
from control lenses (lane a) and 
from  cataractous  transgenic 
mouse lenses  (lane  b).  Protein 
blots  were  incubated  with  the 
polyclonal  antiserum  against 
MP26.  Detection was  achieved 
by  an  alkaline  phosphatase- 
based method. 
Thin sections and freeze-fracture  replicas were examined with an elec- 
tron microscope (EM 400 or EM 410; Philips, Eindhoven, Holland) oper- 
ating at 80 kV. 
Chemicals 
Unless otherwise  indicated,  all chemicals used for this work were pur- 
chased from Sigma Chemical Co. (St. Louis, MO). 
Results 
Generation of  Mice Transgenic for the Human 
MDR3 Gene 
Several transgenic mice strains (VO1 to VO8), have been 
generated (Smit et al.,  manuscript in preparation) by in- 
jecting an MDR3 P-glycoprotein mini-gene under the con- 
trol of the hamster vimentin promoter into fertilized mouse 
oocytes. This promoter drives the expression of the trans- 
gene in all tissues in which the vimentin gene is normally 
expressed, i.e., in tissues of mesenchymal origin and in the 
eye lens (52). 
Detection of  MDR3 RNA and MDR3 Pgp in Transgenic 
Lens Extracts 
We have previously shown that immortalized transgenic 
fibroblast cells derived from the VO1 mouse strain contain 
a high level of MDR3 mRNA which is translated into full- 
length  MDR3  Pgp  and  routed to the plasma  membrane 
Dunia et al. Human Multidrug Resistance 3 P-Glycoprotein  703 Figure 3.  (A) Histological section (LR white) of transgenic mouse embryonic eye (day 14). Note the normal organization of the lens pri- 
mary fibers (F), the lens anterior epithelium (E), and all other ocular tissues.  Bar, 300 ixm. (B) Cryosection of a control embryonic eye 
(day 14), incubated with the Pgp-reactive mAb C219. Note the presence of highly fluorescent ocular connective-tissue derivatives sur- 
rounding the lens. In contrast, the lens appears completely negative. E, epithelium; F, primary fibers. Bar, 125 Ixm. (C and D) Cryosec- 
tions of transgenic mouse embryonic lenses (day 14) incubated with the C219 antibody. MDR3-Pgp is present only in a few randomly 
scattered primary fibers. Bars: (C) 150 Ixm; (D) 200 I~m. 
(59, 65). Fig. 1 shows that MDR3 mRNA can be detected 
in the lens of newborn transgenic mice, but not in that of 
control  mice.  In agreement  with  these  results,  a  protein 
migrating at ~170 kD, the relative mobility of full-length 
glycosylated MDR3  Pgp  (58),  was  detected  in  immuno- 
blots  of isolated  lens  plasma  membranes  from newborn 
transgenic  mice  (Fig.  2  A,  lane  a),  but  not  from control 
mice (not shown). The C219 antibody used in these exper- 
iments reacts with all human and murine Pgps. No 170-kD 
band was found in samples of isolated plasma membranes 
from adult cataractous transgenic lenses (Fig. 2 A, lane b), 
but instead there was a prominent band at  100 kD, which 
was also present in other lanes in Fig. 2 A.  Several bands 
ranging from N80 kD to 150 kD were recognized by C219 
in  immunoblots  of control mouse  ocular tissues  after  re- 
moval of the lens (Fig. 2 A, lane c). Whether these bands 
are due to Pgp degradation products or cross-reacting pro- 
teins remains to be established. 
The Journal of Cell Biology,  Volume 132, 1996  704 Figure 4.  (A) Confocal laser scanning microscopy on a cryosection of newborn transgenic mouse lens incubated with the C219 antibody. 
The MDR3 expression appears distributed in a mosaic fashion, particularly in the lens fibers (F) lying underneath the anterior epithe- 
lium (E). Bar, I00 p~m. (B and C) Confocal laser scanning microscopy on cryosections of newborn transgenic mouse lenses incubated 
with an MP26 antibody. Note the great variety of shape and orientation of the fibers (F) outlined by the intense fluorescence of the 
membrane profiles.  The fibers (F) lying underneath the epithelium (E) are no longer detectable, and areas of liquefaction (Lq) are visi- 
ble in regions where MP26 forms clusters of intensely fluorescent granular material. Bar, 100 Ixm. (D) Confocal laser scanning micros- 
copy on cryosection of control newborn mouse lens incubated with MP26 antibody. The typical aspect and regular pattern of the fiber 
membrane profiles are outlined by the antibody. Bar, 200 nm. 
Immunoblots  stained  with  the  antibody  raised  against 
MP26, the major intrinsic membrane protein of the lens fi- 
bers,  indicate  that  the  isolated  fiber plasma  membranes, 
after 4 M  urea extraction, contain MP26 but not its degra- 
dation product,  MP22. This pattern  is present  in the iso- 
lated plasma membranes from newborn  (not shown)  and 
adult cataractous lenses of transgenic mice (Fig. 2 B). 
Gross Defects in Eyes of Transgenic Mice 
The shape, size, and transparency of lenses from E12-E14 
transgenic embryos were comparable  to those  of control 
mice, but in newborns the transgenic  lenses were smaller 
and  softer  than  in  controls.  Adult  mice  developed  mi- 
crophthalmia. Histological sections revealed that the rem- 
Dunia et al. Human Multidrug Resistance 3 P-Glycoprotein  705 Figure 5.  Cryosection of newborn transgenic mouse lens incubated with C219 antibody. Elongating fibers display uneven distribution of 
the transgene product which appears in a mosaic fashion. Note the presence of highly fluorescent material either filling the fibers or out- 
lining the membranes (arrows).  Bar, 50 p~m. 
nant lens appeared more like a bladder than a compact cel- 
lular mass (see also Fig. 8 A). 
lmmunocytochemistry of  Embryonic Lenses 
In Fig. 3 A, the normal cell organization of the transgenic 
embryonic lens is shown. The C219 antibody stains a few 
randomly  scattered  cells  (mainly  primary  fibers)  in  the 
transgenic lens (Fig. 3, C and D), but not in control lenses 
(Fig.  3  B).  In  addition,  other  eye  tissues  are  intensely 
stained  with  C219,  both in  the  transgenics  and  controls 
(Fig. 3 B). This may be due to endogenous mouse Pgps, 
which are also recognized by C219. 
In both transgenic and control lenses, vimentin is uni- 
formly distributed in primary and secondary fibers and in 
the anterior epithelial layer. Antibodies against MP26 re- 
act with the lens fiber plasma membranes but not with the 
epithelium in both transgenic and control embryonic lenses 
(not shown). 
Immunocytochemistry and Electron Microscopy 
of  Lenses  from Newborn and Adult Transgenic  and 
Control Mice 
In newborn transgenic mouse lenses, the MDR3-Pgp de- 
tected by fluorescence with the C219 antibody is dramati- 
cally increased in comparison with the embryonic stages. 
However, the expression is still not uniform, but very high 
in some cells, whereas in others, particularly in the ante- 
rior lens epithelium, MDR3-Pgp is not detectable (Figs. 4 
and 5). The MDR3-Pgp appears to be present mainly as 
the equatorial/epithelial cells elongate, orient themselves 
obliquely, and come to lie beneath the epithelium. Nucle- 
ated bow fibers are also occupied by C219-reactive material, 
The Journal of Cell Biology, Volume 132, 1996  706 Figure 6.  (A and B) Thin sections of newborn transgenic mouse lenses stained with uranyl acetate and lead citrate. The fiber cytoplasm 
is occupied by many vacuoles of different sizes and shapes containing either amorphous material (A, arrow) or sequestrated membrane 
remnants (B, arrow). Bar, 30 nm. 
Dunia et al. Human  Multidrug Resistance  3 P-Glycoprotein  707 Figure Z  (A and B) Cryosections of transgenic mouse lens fragments extracted with Triton X-100 and immunogold labeled with C219 
antibody. Note that the gold particles are labeling amorphous material closely attached to the cytoplasmic sides either of the vesicular 
profiles (small arrows) or of junctional complexes (arrowheads). Gold particles are also visualized on tangential sections going through 
the membrane profiles (thick arrows). Bars: (A) 120 nm; (B) 150 nm. 
and the expression of the transgene is also evident in sev- 
eral primary fibers of the lenticular core (Fig. 5). Fluores- 
cence appears either associated with amorphous cytoplas- 
mic material or outlining the plasma  membrane  (Fig.  5, 
arrows).  Many cells expressing MDR3  have a  polygonal 
shape,  while  some  others  fuse  together  forming  rather 
large cellular conglomerations underlining the anterior ep- 
ithelium  or  the  posterior capsule  (Fig.  4  A).  Using  the 
MP26 antibody, the honeycomb arrangement, characteris- 
tic of the control lens fibers (Fig. 4 D), is no longer appar- 
ent. The fibers display a large variation in shape, thickness, 
and orientation (Fig. 4, B and C). Internalization of mem- 
brane and junction domains is also a predominant feature. 
In the lens regions where the C219 staining is highest, cell 
fusion  and  liquefaction  are  detectable.  In  these  areas, 
staining with the MP26 antibody shows disruption of the 
plasma  membranes  and  a  granular  material  dispersed 
within the fused fibers (Fig. 4 B). In control newborn mice, 
transgene  expression, monitored  with  the  C219  fluores- 
cence, was totally absent in all lenticular cells. Intense flu- 
orescence was present only in the remnants of the hyaloid 
vascular system and in other derivatives of ocular connec- 
tive tissue, as also shown in embryonic control eyes (Fig. 3 B). 
Electron  microscopic  sections  of  newborn  transgenic 
mouse lenses show the presence of many cytoplasmic vac- 
uoles (Fig. 6 A) absent in control mice. These vesicles have 
different sizes and shapes and contain internalized mem- 
brane profiles and amorphous material (Fig. 6 B). Immu- 
nogold labeling  of cryosections with the  C219 antibody, 
particularly of Triton-extracted lens  samples,  shows  that 
many gold particles are associated either with amorphous 
material  or  with  internalized  membranes  and  junctions 
(Fig. 7, A and B). 
The advanced stages  of lens pathology of adult trans- 
genic mice are characterized by swollen fibers and abla- 
tion of the central lenticular core. The anterior and poste- 
rior sutures  become undetectable,  and  the  lens  appears 
more like a bladder than a compact cellular suborgan (Fig. 
8 A). The lenticular tissue is surrounded by a  thick cap- 
sula. Underneath this fibrillar coat, a layer of either polyg- 
onal or elongated flattened cells is present surrounding the 
central cavity (Fig. 8, A and C). The cells forming the wall 
of the  lens  bladder possess  a  well-developed ER,  mito- 
chondria,  and  Golgi apparatus  (Fig.  8  C).  They contain 
thick  bundles  of  vimentin  intermediate  filaments  (not 
shown). 
Immunocytochemistry on  cryosections of adult  trans- 
genic mouse cataractous lenses, using specific antibodies 
against Pgp (Fig. 8 B) and vimentin, respectively (Fig. 8 C, 
inset),  reveals that many cells express these proteins. 
In this material, some polygonally shaped cells are char- 
acterized by a great number of surface projections and mi- 
The Journal of Cell Biology, Volume 132,  1996  708 Figure 8.  (A) Histological section (LR white) of a cataractous adult transgenic mouse lens. The lens appears as a bladder surrounded by 
a thick capsule and formed by multilayered,  round-shaped, and elongated nucleated cells. The bladder cavity is occupied by swollen cel- 
lular debris. Bar, 150 I~m. (B) Confocal laser scanning  microscopy on cryosection of a cataractous adult transgenic mouse lens incubated 
with C219 antibody. Note the mosaic distribution of the transgene product highly expressed in elongated multilayered cells. Note that 
the capsule (C) is not stained. Bar, 60 I~m. (C) Thin section of the wall of the lens bladder in a transgenic mouse adult cataractous lens, 
stained with uranyl acetate and lead citrate. The cells are characterized by a well-developed, rough ER (arrows).  Note the presence of 
cytoplasmic vacuoles and shedded membranes (arrowheads).  L, lumen; C, capsule. Bar, 2 I~m. (Inset) Cryosection of the same material 
incubated with anti-vimentin  antibody, showing the mosaic distribution of this protein. F, fibers; C, fragment of capsule detached from 
the lens during sectioning. Bars: (C) 200 nm; (inset) 80 p~m. 
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cellular projections appear pinched off from the  plasma 
membrane and lie as individual round or oval structures in 
the extracellular domain (Fig. 9 A). Immunofluorescence 
(Fig. 9 B) and immunogold labeling (Fig. 9 A, inset), using 
antibodies against MP26, show that this protein is associ- 
ated with the surface of cell projections. 
Freeze Fracture of Lenses from Embryonic, Newborn, 
and Adult Transgenic and Control Mice 
Embryonic lenses of transgenic mice are characterized by 
freeze-fracture features comparable to those found in con- 
trol mice. The intramembranous  particles  (IMP)  of the 
protoplasmic fracture face (PF) and the pits, characteristic 
of the  external fracture face  (EF)  of the  plasma  mem- 
brane, are randomly distributed (not shown). 
In newborn transgenic mouse lenses, freeze fracture of 
the  outer  cortical  fiber  plasma  membranes  reveals  the 
presence of large areas of PF occupied by tetrameric IMP 
forming a lattice of packed arrays (Fig. 10).  Such square 
arrays are also present in deeper regions of the lens. In the 
newborn control lenses, the same arrays are only restricted 
to the nuclear fiber plasma membranes (not shown). 
The plasma  membrane of the  adult cataractous trans- 
genic mouse lens cells is characterized by an impressive ac- 
cumulation  of tetrameric  IMP  arrays  on  the  PF,  either 
forming randomly scattered small clusters or large square 
lattices of repeating subunits (Fig. 11 A) often interspaced 
by areas devoid of particles (Fig. 11 B). The cells forming 
the lenticular cataractous wall can be easily recognized be- 
cause they have an  elongated shape  and fingerlike pro- 
cesses. Freeze fracture of these cells reveals that their PFs 
are characterized, in addition to the square arrays (Figs. 10 
and 11), by the presence of 8-rim particles, exhibiting clus- 
ter distribution or forming interlaced rows (Fig. 12, A  and 
C). Typical gap junctions are also present, being character- 
ized by both geometrically packed arrays of 8-nm repeat- 
ing subunits, or by large nongeometric assemblies of 8-nm 
repeating subunits (Fig. 12, B and D). 
Discussion 
Expression of the MDR3-Pgp in the Lens 
Our  results  demonstrate  that  the  human  MDR3  gene, 
driven by the vimentin promoter, is expressed in lenticular 
cells. The level of expression, monitored by immunofluo- 
rescence, is prominent in the newborn and adult mouse 
lens.  mAb  C219,  which we  have used  as immunoprobe, 
recognizes all mammalian Pgps (28), and we have shown 
that no Pgps are present in the normal eye lens. This fact 
made it possible to identify both the onset and site of pro- 
duction of the MDR3-Pgp in the lens and to characterize 
tissue alterations when the ectopic Pgp becomes expressed. 
Differing from the endogenous vimentin expression (20, 
21, 38, 56), the occurrence of MDR3-Pgp is not uniform, 
but  follows  a  randomly  dispersed  mosaic  pattern.  The 
number of cells expressing the transgene increases from 
newborn to adult lenses. Therefore, the MDR3-Pgp pro- 
duction, although remaining patchy, can account for the 
progressive and extensive damages leading to cataract. 
The expression of Pgps in eye tissues other than the lens 
is presumably not the cause of lens damage since during 
the embryonic stages, the derivatives of ocular connective 
tissue fully express the transgene or the endogenous Pgps, 
while the lens displays a normal organization, and its de- 
velopment proceeds unaffected. 
Ultrastructural Features of the Lens 
Expressing MDR3-Pgp 
The early ultrastructural  alterations  in  the MDR3-Pgp- 
expressing lens cells are characterized by the presence of 
cytoplasmic vacuoles of different size and shape, many of 
them  containing  internalized  membrane  profiles  and 
amorphous  material.  Immunofluorescence  and  immu- 
nogold labeling reveal that the MDR3-Pgp is mainly asso- 
ciated to the plasma  membrane outlining the fiber con- 
tours and to the membrane-internalized profiles. Moreover, 
immunoblotting  experiments  using  the  antibody  raised 
against  P-glycoproteins  (mAb  C219)  demonstrate  that 
MDR3-Pgp is associated to the isolated lens plasma mem- 
branes. 
At more advanced stages of damage, the inner cortex 
and the lenticular core show liquefaction areas within the 
fibers, and the lens is transformed into a cavity comprising 
cellular debris. The wall of this cavity consists of flattened 
overlapping cells, with a  fully differentiated nuclear and 
cytoplasmic organization, characterized by a great number 
of surface projections. Many of these cells express MDR3- 
Pgp and vimentin. Since they express MP26 too, presum- 
ably, they are epithelial cells committed to terminal differ- 
entiation and elongation into fibers. Moreover, they are 
also  characterized by membrane  domains  displaying  all 
different stages of gap junctional assembly characteristic 
of the process of fiber elongation (2) (Fig. 12, A and C). 
All these data lead us to the conclusion that the expres- 
sion of MDR3-Pgp in transgenic mouse lenses affects the 
organization  of  the  plasma  membrane,  particularly  of 
MP26. This major intrinsic polypeptide of lens fiber mem- 
branes (also called MIP or aquaporine) belongs to a super- 
family of putative  transmembrane  channel-forming pro- 
teins widespread among living organisms from mammals 
to bacteria (3, 11, 22). Major functions of this superfamily 
include the control of water (49, 74, 75) and ion permeabil- 
ity (12, 14, 15, 50). In normal lens fibers and in reconsti- 
tuted  proteoliposomes containing exclusively MP26,  the 
protein forms tetrameric oligomers randomly dispersed in 
the  bilayer (19).  Furthermore, the  MP26  oligomers can 
Figure 9.  (A) Thin section of cellular elements  forming the wall of the lens bladder in an adult cataractous  transgenic mouse lens, 
stained with uranyl acetate and lead citrate. Note the presence of a great number of surface projections and swollen microvilli occupying 
the membrane surface. (Inset) Ultracryosection  of the same material incubated with the MP26 antibody. Note that a discrete immu- 
nogold labeling outlines the cell surface projections (arrows). Bars: (A) 1 txm; (inset) 125 nm. (B) Cryosection of a cataractous  adult 
transgenic mouse lens, immunolabeled  with the MP26 antibody. The MP26 fluorescent material is associated either with the plasma 
membrane or with granular material in the cell cytoplasm. Bar, 50 nm. 
Dunia et al. Human Multidrug Resistance  3 P-Glycoprotein  711 Figure 10.  Freeze-fracture replica of a newborn transgenic mouse lens. The protoplasmic fracture face (PF) is characterized  by a great 
number of small clusters of square arrays of IMPs. Bar, 120 nm. 
form, both  in  situ  and  in  reconstituted  proteoliposomes 
(19, 46), square arrays of tetrameric subunits. However, in 
normal lenses, the lattice organization is restricted to the 
plasma membranes of the nuclear fibers (3, 13, 22, 39, 43). 
This type of membrane organization has been tentatively 
correlated  with  posttranslational  degradation  of  MP26 
into MP22 that normally occurs in aged nuclear fibers (3, 
13,  22,  39,  43).  Square  arrays of tetrameric subunits,  al- 
though  to  a  limited  extent,  have  been  described  in  the 
nonosmotic hereditary cataract in aged Emory mice, which 
is a model for senile lens opacification (44, 45, 69). 
Our freeze-fracture experiments show that  large  accu- 
The Journal of Cell Biology, Volume 132, 1996  712 Figure 11.  (A and B) Freeze-fracture replica of a cataractous transgenic mouse lens. (A) PF fracture faces displaying a great number of 
square arrays of tetragonal particles.  (B) IMPs are assembled in large clusters of tetragonally packed repeating subunits, interspaced by 
areas void of particles. Bars: (A) 50 nm; (B) 80 nm. 
mulations  of  square  arrays  of  tetrameric  subunits  are 
present  in  cortical  fiber plasma membranes of newborn 
transgenic  lenses.  This  freeze-fracture  feature  becomes 
more pronounced in cataractous lenses. The massive ap- 
pearence  of  square  arrays  in  MDR3  transgenic  mouse 
lenses seems not to be associated with the proteolytic deg- 
radation  of MP26.  This is shown by our immunoblotting 
experiments using an MP26 antibody. The square array of 
MP26 tetrameric subunits in MDR3 transgenic mouse lens 
fibers may therefore reflect changes in the membrane lipid 
environment.  Actually, the  square  lattice,  present  in  the 
aged nuclear fiber membranes of a  normal lens, not only 
coincides  with the  posttranslational  processing  of MP26, 
but also, if not primarily, with changes of the lipid compo- 
sition of the plasma membranes. In a normal lens, the ag- 
ing process of the fiber plasma membranes is characterized 
by loss of phospholipids, in particular phosphatidylcholine 
(7, 9, 24). The nuclear fiber membranes contain less than 
one-third  of the  concentration  of the  total  phospholipid 
present in the cortex, with a corresponding increase of the 
cholesterol/phospholipid ratio (24), 
Characteristics of Lens Abnormalities in Transgenic 
Mouse Lenses 
Although  cataracts  have  been  described  in  other  trans- 
genic mice, these opacifications lack the characteristic os- 
motic features of the cataracts in mice overexpressing the 
MDR3 gene. Cataracts generated in lenses overexpressing 
dominant mutations of intermediate filament genes driven 
by the  vimentin promoter (4,  6,  20, 21)  or in  transgenic 
mice overexpressing the retinoic acid receptor protein tar- 
geted to the lens by the aA-crystallin promoter (1) lacked 
a prominent osmotic component. Even overexpression of 
an ectopic single-pass membrane protein, the H-2D  d ma- 
jor histocompatibility complex class I  chain (47), did not 
induce the distinct alterations of the lens membrane orga- 
nization observed in MDR3 transgenic mice. 
Dunia et al. Human Multidrug Resistance 3 P-Glycoprotein  713 Figure 12.  Freeze-fracture replica of a cataractous transgenic mouse lens. (A and C) The fracture reveals two classes of particles on the 
PF: particles of heterogeneous size between 4 and 7 nm, and 8-nm particles forming linear arrays or clusters. Bar, 70 nm. (B and D) The 
fracture reveals macular gap junctions either characterized by a hexagonal array of pitted images on EF and geometrical packing of 8-nm 
particles on PF (D), or by nongeometrical clusters of 8-nm particles (B). Arrows point to EF and PF, respectively. Bars: (B) 120 nm; (D) 
80 nm. 
The ultrastructural abnormalities detected in the lens of 
newborn and adult transgenic mice expressing the MDR3- 
Pgp have morphological features  in  common with those 
described in the osmotic cataracts of Nakano, Philly, and 
Fraser (CAT) mice (8, 25, 32, 36, 40, 51, 67, 69, 71). These 
cataracts  develop  either  during  embryonic life  or  after 
birth and are characterized by the osmotic swelling of cy- 
toplasmic membrane compartments, internalization of mem- 
brane profiles, and liquefaction of the lenticular core. The 
osmotic cataract in Nakano mice is characterized by the 
presence of a protein factor that inhibits the Na  ÷,K+-ATP- 
ase  and  by  posttranslational  processing  of  MP26  into 
MP22 (25-27, 40, 67, 69). In Philly mice, a deletion of four 
amino acids has been identified in a region nearby the car- 
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and protein-protein interactions  of this protein (8). The 
osmotic  cataracts  in both  Nakano  and Philly mice  have 
been tentatively correlated with an accelerated  degrada- 
tion of MP26 (55). 
In  mice  affected  by  the  dominant  Fraser  mutation 
(CATFr), lens opacification develops ~day 14 of gestation. 
The swelling of lens fibers correlates with a defect in the 
ionic  balance  (36).  Furthermore,  the  mRNA  profile  of 
CAT  lenses  is  consistent  with a  mutation  in  the mouse 
MP26 gene, which results  in truncation of MP26 mRNA 
(48, 49, 61--63). 
Strikingly, in the three types of congenital osmotic cata- 
racts  mentioned,  a  major  feature  is  either  an  inherited 
dominant defective expression or a degradation process of 
MP26, in addition to other changes in the metabolism of 
crystallins (8, 36, 40, 51, 76). 
Role of  MDR3-Pgp Expression in Lens Damage 
Several  mechanisms  can  be  envisaged  by which  the  ex- 
pression of MDR3-Pgp  might cause the observed abnor- 
malities. The MDR3 gene is the human homologue of the 
mouse mdr2 gene, and it has recently been shown that an 
MDR3 transgene can rescue the liver abnormalities in an 
mdr2  (-/-)  mouse  homozygous for  a  disruption of the 
mdr2 gene (Smith, A. J., and P. Borst, unpublished obser- 
vations). The mdr2-Pgp  is a phosphatidylcholine translo- 
cator that probably acts as a "flippase," transferring phos- 
phatidylcholine  from  the  inner  leaflet  of  the  plasma 
membrane to the outer leaflet (64). In the presence of bile 
salts (64) or phosphatidylcholine transfer protein (66), the 
action of the mdr2/MDR3  translocator may promote ex- 
port of phosphatidylcholine from the cell. In the absence 
of such a phospholipid acceptor, i.e., in lens fiber cells, no 
net phospholipid export can be expected  (54, 66), but the 
action of the translocator might still result in an abnormal 
distribution of phospholipid species between the two leaf- 
lets of the plasma membrane. This, in turn, might induce 
lattice assembly of MP26, affecting the channel properties 
of this protein.  The  new vectorial  organization of mem- 
brane  phospholipids  might  also  generate  a  lipid  bilayer 
configuration  promoting  membrane  fusion,  internaliza- 
tion,  and  budding of  surface  projections  (17),  processes 
identified in the MDR3 transgenic lenses. We cannot ex- 
clude, however, that the insertion of a bulky glycoprotein 
into the plasma membrane would in itself be sufficient to 
disturb the membrane function, even if it had no direct ef- 
fect on phospholipid distribution. It is conceivable, for in- 
stance, that the MDR3-Pgp could modify either the func- 
tion of gap junction constituents  (29, 30, 41) or of active 
transporters (26, 27). 
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